Doctor’s Seminar: BromSiteTM – First NSAID, FDA-approved for prevention of ocular pain in patients undergoing cataract surgery featuring Dr. Jay Pepose, Medical Director, Pepose Vision Institute
We’re pleased to welcome three more Board Members: Donna Hibler, Captain Eichel Johnson and Dr. Elizabeth Schmitz. Each brings valuable experience and passion and will be great additions to our strong Board.
New Doctor’s Seminar : Innovations in surgical vision correction and pharmaceutical advances sparking FDA Trials
Doctor’s Seminar : Pathophysiology, Diagnosis, and Latest Advancements in the Management of Keratoconus: Collagen Cross-Linking and Intacs, featuring Dr. Mujtaba A. Qazi, Director, Clinical Studies, Pepose Vision Institute
We are pleased to announce our clinical research study designed to evaluate the safety and efficacy of iontophoresis treatment with dexamethasone phosphate ophthalmic solution in patients who have non-infectious anterior segment uveitis. Iontophoresis is an investigational drug delivery system which...
New Clinical study: Announcing a new important clinical trial for wet AMD. This trial will investigate the safety and efficacy of a new, Ranibizumab sustained delivery platform for patients with wet AMD. This is a Genentech Phase II trial...
Vision Mission to Haiti: June 8-13, 2016 We are pleased to announce that Lifelong Vision Foundation sent Dr. Nancy Holekamp on our 2016 Vision Mission to La Gonave, Haiti. Dr. Holekamp provided vision screening and refraction tests to more than 400 kids...
New Doctor’s Seminar June : Dry Eyes and Allergies: Unique testing and treatments, featuring Dr. Jay Pepose, Medical Director, and Dr. Mujtaba A. Qazi, Director, Clinical Studies, Pepose Vision Institute
